Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Guillebaud

Showing results (111-120 of 127) with videos related to

Pageof 13
Sort By:
Lancet (London, England)|July 2, 1994
Fatherhood without apparent spermatozoa after vasectomyJ C Smith, D Cranston, T O'Brien, et al.
British Medical Journal|December 4, 1976
Weak autoantibody reactions to antigens other than sperm after vasectomyJ D Mathews, D C Skegg, M P Vessey, et al.
Contraception|September 1, 1990
Changes in metabolism induced by oral contraceptives containing desogestrel and gestodene in older womenG E Robinson, W Bounds, I J Mackie, et al.
The British Journal of Family Planning|February 19, 1999
GyneFIX. The frameless intrauterine contraceptive implant--an update for interval, emergency and postabortal contraceptionD Wildemeersch, I Batár, A Webb, et al.
Human Reproduction (Oxford, England)|May 21, 2005
Levonorgestrel intrauterine system (LNG-IUS) with conjugated oral equine estrogen: a successful regimen for HRT in perimenopausal womenN R E Hampton, M C P Rees, D G Lowe, et al.
British Journal of Haematology|July 10, 2001
Protein S levels are lower in women receiving desogestrel-containing combined oral contraceptives (COCs) than in women receiving levonorgestrel-containing COCs at steady state and on cross-overI J Mackie, K Piegsa, S A Furs, et al.
Lancet (London, England)|April 6, 1996
Effect of smoking cessation on cervical lesion sizeA Szarewski, M J Jarvis, P Sasieni, et al.
Health Technology Assessment (Winchester, England)|August 17, 2000
Implantable contraceptives (subdermal implants and hormonally impregnated intrauterine systems) versus other forms of reversible contraceptives: two systematic reviews to assess relative effectiveness, acceptability, tolerability and cost-effectivenessR S French, F M Cowan, D J Mansour, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|October 12, 2000
Levonorgestrel-releasing (20 microgram/day) intrauterine systems (Mirena) compared with other methods of reversible contraceptivesR S French, F M Cowan, D Mansour, et al.
BMJ (Clinical Research Ed.)|February 2, 1991
Changes in haemostasis after stopping the combined contraceptive pill: implications for major surgeryG E Robinson, T Burren, I J Mackie, et al.
Pageof 13

Showing results (111-120 of 127) with videos related to

Sort By:
Pageof 13
Lancet (London, England)|July 2, 1994
Fatherhood without apparent spermatozoa after vasectomyJ C Smith, D Cranston, T O'Brien, et al.
British Medical Journal|December 4, 1976
Weak autoantibody reactions to antigens other than sperm after vasectomyJ D Mathews, D C Skegg, M P Vessey, et al.
Contraception|September 1, 1990
Changes in metabolism induced by oral contraceptives containing desogestrel and gestodene in older womenG E Robinson, W Bounds, I J Mackie, et al.
The British Journal of Family Planning|February 19, 1999
GyneFIX. The frameless intrauterine contraceptive implant--an update for interval, emergency and postabortal contraceptionD Wildemeersch, I Batár, A Webb, et al.
Human Reproduction (Oxford, England)|May 21, 2005
Levonorgestrel intrauterine system (LNG-IUS) with conjugated oral equine estrogen: a successful regimen for HRT in perimenopausal womenN R E Hampton, M C P Rees, D G Lowe, et al.
British Journal of Haematology|July 10, 2001
Protein S levels are lower in women receiving desogestrel-containing combined oral contraceptives (COCs) than in women receiving levonorgestrel-containing COCs at steady state and on cross-overI J Mackie, K Piegsa, S A Furs, et al.
Lancet (London, England)|April 6, 1996
Effect of smoking cessation on cervical lesion sizeA Szarewski, M J Jarvis, P Sasieni, et al.
Health Technology Assessment (Winchester, England)|August 17, 2000
Implantable contraceptives (subdermal implants and hormonally impregnated intrauterine systems) versus other forms of reversible contraceptives: two systematic reviews to assess relative effectiveness, acceptability, tolerability and cost-effectivenessR S French, F M Cowan, D J Mansour, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|October 12, 2000
Levonorgestrel-releasing (20 microgram/day) intrauterine systems (Mirena) compared with other methods of reversible contraceptivesR S French, F M Cowan, D Mansour, et al.
BMJ (Clinical Research Ed.)|February 2, 1991
Changes in haemostasis after stopping the combined contraceptive pill: implications for major surgeryG E Robinson, T Burren, I J Mackie, et al.
Pageof 13